Annual Long Term Debt
$619.30 M
+$522.77 M+541.54%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual long term debt is currently $619.30 million, with the most recent change of +$522.77 million (+541.54%) on 31 December 2023. During the last 3 years, it has risen by +$567.65 million (+1099.03%). AMPH annual long term debt is now at all-time high.AMPH Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$625.39 M
+$9.05 M+1.47%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly long term debt is currently $625.39 million, with the most recent change of +$9.05 million (+1.47%) on 30 September 2024. Over the past year, it has dropped by -$43.02 million (-6.44%). AMPH quarterly long term debt is now -6.44% below its all-time high of $668.40 million, reached on 30 September 2023.AMPH Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +541.5% | -6.4% |
| 3 y3 years | +1099.0% | +519.1% |
| 5 y5 years | +1836.3% | +1036.7% |
AMPH Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1099.0% | -6.4% | +547.9% |
| 5 y | 5 years | at high | +1836.3% | -6.4% | +1181.6% |
| alltime | all time | at high | +6050.6% | -6.4% | +6406.3% |
Amphastar Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $625.39 M(+1.5%) |
| June 2024 | - | $616.34 M(-1.0%) |
| Mar 2024 | - | $622.75 M(+0.6%) |
| Dec 2023 | $619.30 M(+541.5%) | $619.30 M(-7.3%) |
| Sept 2023 | - | $668.40 M(+30.4%) |
| June 2023 | - | $512.69 M(+429.3%) |
| Mar 2023 | - | $96.87 M(+0.3%) |
| Dec 2022 | $96.53 M(-3.0%) | $96.53 M(-1.9%) |
| Sept 2022 | - | $98.38 M(-0.2%) |
| June 2022 | - | $98.55 M(-1.3%) |
| Mar 2022 | - | $99.84 M(+0.4%) |
| Dec 2021 | $99.48 M(+92.6%) | $99.48 M(-1.5%) |
| Sept 2021 | - | $101.02 M(+83.6%) |
| June 2021 | - | $55.02 M(+12.7%) |
| Mar 2021 | - | $48.80 M(-5.5%) |
| Dec 2020 | $51.65 M(-7.3%) | $51.65 M(+2.4%) |
| Sept 2020 | - | $50.44 M(+2.6%) |
| June 2020 | - | $49.15 M(-4.8%) |
| Mar 2020 | - | $51.64 M(-7.3%) |
| Dec 2019 | $55.71 M | $55.71 M(+1.3%) |
| Sept 2019 | - | $55.02 M(-4.4%) |
| June 2019 | - | $57.55 M(+36.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $42.15 M(+31.8%) |
| Dec 2018 | $31.98 M(-21.7%) | $31.98 M(-1.9%) |
| Sept 2018 | - | $32.61 M(-3.2%) |
| June 2018 | - | $33.70 M(-15.1%) |
| Mar 2018 | - | $39.71 M(-2.8%) |
| Dec 2017 | $40.84 M(+26.2%) | $40.84 M(-3.3%) |
| Sept 2017 | - | $42.23 M(+5.3%) |
| June 2017 | - | $40.11 M(+28.8%) |
| Mar 2017 | - | $31.15 M(-3.7%) |
| Dec 2016 | $32.36 M(+7.3%) | $32.36 M(-5.3%) |
| Sept 2016 | - | $34.16 M(+7.6%) |
| June 2016 | - | $31.74 M(+9.1%) |
| Mar 2016 | - | $29.09 M(-3.6%) |
| Dec 2015 | $30.16 M(-16.5%) | $30.16 M(-3.8%) |
| Sept 2015 | - | $31.35 M(-9.9%) |
| June 2015 | - | $34.80 M(-3.0%) |
| Mar 2015 | - | $35.89 M(-0.6%) |
| Dec 2014 | $36.11 M(+258.6%) | $36.11 M(-12.5%) |
| Sept 2014 | - | $41.27 M(-3.7%) |
| June 2014 | - | $42.85 M(+345.8%) |
| Mar 2014 | - | $9.61 M(-4.5%) |
| Dec 2013 | $10.07 M(-36.9%) | $10.07 M |
| Dec 2012 | $15.95 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual long term debt year-on-year change?
- What is Amphastar Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly long term debt year-on-year change?
What is Amphastar Pharmaceuticals annual long term debt?
The current annual long term debt of AMPH is $619.30 M
What is the all time high annual long term debt for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual long term debt is $619.30 M
What is Amphastar Pharmaceuticals annual long term debt year-on-year change?
Over the past year, AMPH annual long term debt has changed by +$522.77 M (+541.54%)
What is Amphastar Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of AMPH is $625.39 M
What is the all time high quarterly long term debt for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly long term debt is $668.40 M
What is Amphastar Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, AMPH quarterly long term debt has changed by -$43.02 M (-6.44%)